Michael Fill to Tachycardia, Ventricular
This is a "connection" page, showing publications Michael Fill has written about Tachycardia, Ventricular.
Connection Strength
0.630
-
Cardiac ryanodine receptor calcium release deficiency syndrome. Sci Transl Med. 2021 02 03; 13(579).
Score: 0.180
-
Non-?-blocking R-carvedilol enantiomer suppresses Ca2+ waves and stress-induced ventricular tachyarrhythmia without lowering heart rate or blood pressure. Biochem J. 2015 Sep 01; 470(2):233-42.
Score: 0.122
-
The cardiac ryanodine receptor luminal Ca2+ sensor governs Ca2+ waves, ventricular tachyarrhythmias and cardiac hypertrophy in calsequestrin-null mice. Biochem J. 2014 Jul 01; 461(1):99-106.
Score: 0.114
-
Decreased RyR2 refractoriness determines myocardial synchronization of aberrant Ca2+ release in a genetic model of arrhythmia. Proc Natl Acad Sci U S A. 2013 Jun 18; 110(25):10312-7.
Score: 0.106
-
Luminal Ca2+ regulation of single cardiac ryanodine receptors: insights provided by calsequestrin and its mutants. J Gen Physiol. 2008 Apr; 131(4):325-34.
Score: 0.074
-
Nebivolol suppresses cardiac ryanodine receptor-mediated spontaneous Ca2+ release and catecholaminergic polymorphic ventricular tachycardia. Biochem J. 2016 Nov 15; 473(22):4159-4172.
Score: 0.033